Jiwei Liu

机构：Mongolian University of Science and Technology, Dalian Medical University, Inner Mongolia University of Science and Technology, First Affiliated Hospital of Dalian Medical University · ORCID：0000-0001-5040-6242

发表论文 131 篇 · 总被引 8693 次 · h-index 29

代表论文

• Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): 4-year outcomes from a double-blind, randomised, phase 3 trial (2025 · The Lancet Oncology · 被引 17)
• Machine Learning for Predicting Primary Graft Dysfunction After Lung Transplantation: An Interpretable Model Study (2025 · Transplantation · 被引 6)
• E3 ligase TRIM22 promotes melanoma proliferation by regulating cell cycle progression through K63-linked ubiquitination of p21 (2025 · Scientific Reports · 被引 4)
• TSZAF monomer combination downregulates the Wnt/β-catenin signaling pathway and inhibits neutrophil recruitment to prevent lung cancer metastasis (2025 · Chinese Journal of Natural Medicines · 被引 3)
• Irinotecan plus raltitrexed as second-line treatment in locally advanced or metastatic colorectal cancer patients: a prospective open-label, single-arm, multi-center, phase II study (2024 · BMC Cancer · 被引 3)
• From awareness to action: Revolutionizing cardio-oncology in China (2025 · Seminars in Cancer Biology · 被引 2)